SC 13G Filing

Company

CRESCENT BIOPHARMA, INC.

Filed

November 27, 2024

Accession Number

0000935836-24-000745

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →